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Myocardial ischemia may occur during an exercise session in cardiac rehabilitation programs. However, it has not been established
whether it is elicited when exercise prescription is based on heart rate corresponding to the anaerobic threshold as measured by
cardiopulmonary exercise testing. Our objective was to determine the incidence of myocardial ischemia in cardiac rehabilitation
programs according to myocardial perfusion SPECT in exercise programs based on the anaerobic threshold. Thirty-nine patients
(35 men and 4 women) diagnosed with coronary artery disease by coronary angiography and stress technetium-99m-sestamibi
gated SPECT associated with a baseline cardiopulmonary exercise test were assessed. Ages ranged from 45 to 75 years. A second
cardiopulmonary exercise test determined training intensity at the anaerobic threshold. Repeat gated-SPECT was obtained after
a third cardiopulmonary exercise test at the prescribed workload and heart rate. Myocardial perfusion images were analyzed using
a score system of 6.4 at rest, 13.9 at peak stress, and 10.7 during the prescribed exercise (P < 0.05). The presence of myocardial
ischemia during exercise was defined as a difference ≥2 between the summed stress score and summed rest score. Accordingly,
25 (64%) patients were classified as ischemic and 14 (36%) as nonischemic. MIBI-SPECT showed myocardial ischemia during
exercise within the anaerobic threshold. The 64% prevalence of ischemia observed in the study should not be looked on as
representative of the whole population of patients undergoing exercise programs. Changes in patient care and exercise programs
were implemented as a result of our finding of ischemia during the prescribed exercise.
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Introduction
According to current guidelines, exercise intensity in
cardiac rehabilitation programs should not precipitate myo-
cardial ischemia during a training session (1-6). However, it
has been shown by SPECT myocardial perfusion imaging
that physical exercise within the functional capacity, based
on standard exercise stress testing, may cause ischemia,
characterized by a reversible perfusion defect, even without
angina symptoms or ST-segment depression (7).
With the current widespread use of cardiopulmonary
exercise testing, exercise intensity can be defined on the
basis of the anaerobic threshold (8-11). At this level of
physical exertion, exercise training improves the overall
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functional capacity of the patients and may be applied
even to those with coronary artery disease and ventricular
dysfunction (12,13). However, it has not yet been estab-
lished whether exercise intensity determined by anaerobic
threshold elicits myocardial ischemia.
Myocardial perfusion studies are more effective in iden-
tifying exercise-induced ischemia than other methods used
for the diagnosis and risk stratification of obstructive ath-
erosclerotic coronary artery disease (14-16). The objec-
tive of this study was to assess the incidence of myocardial
ischemia in exercise prescription based on the anaerobic
threshold in cardiac rehabilitation programs, using the
myocardial perfusion SPECT test.
Material and Methods
From June 2005 to September 2006, 153 consecutive
patients referred to the Nuclear Medicine Department of
Instituto Dante Pazzanese de Cardiologia were assessed.
All of them showed reversible defect on myocardial perfu-
sion SPECT images and ≥70% diameter stenosis on coro-
nary angiography in at least one of the three main coronary
arteries (left anterior descending artery, right coronary
artery, left circumflex artery, and their branches). At the
initial analysis, 95 patients with at least one of the following
characteristics were excluded: age over 75 years, pres-
ence of atrial fibrillation, pacemaker, left bundle branch
block, preexcitation syndrome, hemodynamically signifi-
cant valvular heart disease, difficulty in undergoing study
procedures appropriately, impossibility to participate in an
exercise program after the study, and patients already
attending a cardiac rehabilitation program. The remaining
58 patients underwent history taking, clinical examination,
and standard 12-lead electrocardiography, in addition to
repeat SPECT myocardial perfusion following a cardiopul-
monary exercise test using a Medical Graphics CardiO2
system (USA). This was performed without discontinua-
tion of any medication taken regularly. An individualized
ramp protocol with a cycle ergometer was used. Criteria for
exercise termination were those established by the Ameri-
can College of Cardiology and American Heart Associa-
tion guidelines (17). A 740 Mbq (or 20 mCi) amount of
technetium-99m-sestamibi (99mTc-sestamibi) was admin-
istered to patients weighing 85 kg or less, and an amount
of 0.31 mCi/kg was administered to those weighing more
than 85 kg. The radiotracer was injected at near-maximum
heart rate (HR; defined as 220-age) or in the presence of
impending exhaustion, exertional ST-segment depression
equal to or greater than 0.3 mV, or angina pectoris. After
the injection, exercise was continued for 30 to 60 s, and
myocardial perfusion SPECT was performed 60 min later.
Rest myocardial perfusion SPECT was performed within a
week of the first cardiopulmonary exercise test. Under
regular medication, only 39 patients showed a persistent
reversible defect on myocardial perfusion SPECT images
and were eligible for the next phase of the study. Thirty-five
of them were men (89%) and 4 were women (10.3%). Ages
ranged from 45 to 73 years (mean 59.76), and mean body
mass index was 28.4.
The second cardiopulmonary exercise test was similar
to the first, but was not associated with myocardial perfu-
sion imaging, and was used to determine the anaerobic
threshold using the V-slope method (18). Training level
was set at the workload and HR corresponding to the
anaerobic threshold. The third cardiopulmonary exercise
test was performed at the workload prescribed for tests on
mechanically braked bicycles, the same as used in the
cardiac rehabilitation program, during over a period of 20
min, corresponding to the continuous aerobic phase of a
cardiac rehabilitation program session. The 99mTc-sestamibi
dose was injected approximately 19 min into the test, and
images were acquired 60 min later.
Both stress and rest SPECT images were processed
using the QGS (CEDAR) dedicated software (19). Qualita-
tive and semiquantitative analyses were performed. Ra-
diotracer uptake was compared in 17 segments of the
myocardium. Myocardial perfusion images were analyzed
by 3 observers blind to patients’ data using a score system
for each of the 17 segments based on five tomographic
views: basal short-axis slice, midventricular short-axis slice,
apical short-axis slice, vertical long-axis slice, and horizon-
tal long-axis slice. For each slice, the segment with the
highest uptake was graded zero. The remaining segments
were graded according to the following criteria: one, mildly
reduced uptake; two, moderately reduced uptake; three,
severely reduced uptake, and four, absent uptake. For
each SPECT image, a summed score was obtained by
adding the 17 segmental scores. No difference between
the summed stress score and summed rest score indi-
cated absence of stress-induced hypoperfusion, that is to
say, absence of ischemia. Myocardial ischemia is defined
as a difference ≥2 between stress and rest scores, accord-
ing to the study by Berman et al. (20), a criterion that has
been used in recent landmark studies (21).
Statistical analysis was performed using repeated-
measures analysis of variance (ANOVA). The Bonferroni
multiple comparison test was used to detect differences
between cardiopulmonary exercise tests and the scores
derived from SPECT images obtained at rest, at peak
stress, and during the prescribed exercise. Summed differ-
ence score (peak - rest and prescription exercise - rest)
were compared by the Wilcoxon test. P values ≤0.05 were
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considered to be statistically significant. All scores for the
three situations mentioned above are presented as means
and 95% confidence intervals (95%CI). Mean HR was
compared using the paired Student t-test. ST-segment
changes between rest, 99mTc-sestamibi injection at peak
stress and prescribed exercise were analyzed by the
McNemar test. The Pearson chi-square test or the Fisher
exact test was used to determine association among groups
with summed difference score (≥2 and <2) in relation to
clinical, angiographic and electrocardiographic data. Age
was compared by the Student t-test.
The study protocol was approved by the Research
Ethics Committees of UNIFESP (Universidade Federal de
São Paulo, Escola Paulista de Medicina) and Instituto
Dante Pazzanese de Cardiologia, and all patients signed a
consent form after being fully informed about the proce-
dures involved in writing.
Results
The clinical and angiographic characteristics of the
patients are shown in Table 1. Coronary angiography
revealed significant stenosis involving the left anterior
descending artery in 27 patients, the right coronary artery
in 25 patients, and the left circumflex artery in 28 patients
The cardiopulmonary variables evaluated in all three
cardiopulmonary exercise tests are shown in Table 2.
Table 1. Clinical and angiographic characteristics of the 39 pa-
tients who participated in this study.
Variables N (%)
Hypertension 37 (94.9%)
Dyslipidemia 37 (94.9%)
Diabetes mellitus 18 (46.2%)
Smoking 4 (10.3%)
Past smoking 18 (46.2%)
Angina pectoris 18 (46.17%)
Intermittent claudication 2 (5.13%)
Myocardial infarction 8 (20.51%)
Myocardial infarction and CABG and/or PCI 9 (23.07%)
CABG and/or PCI 12 (30.77%)
Uneventful 10 (25.65%)
Aspirin 35 (89.7%)
Beta-blockers 24 (61.5%)
Statins 34 (87.2%)
ACE inhibitors 30 (76.9%)
Vasodilators 23 (59%)
Oral hypoglycemic drugs 16 (41%)
Diuretics 8 (20.5%)
Single-vessel disease 8 (20.5%)
Two-vessel disease 21 (53.9%)
Three-vessel disease* 10 (25.6%)
CABG = coronary artery bypass graft surgery; PCI = percutane-
ous coronary intervention; ACE = angiotensin-converting en-
zyme. *Nine patients underwent revascularization procedures.
Of these, 7 were reevaluated later, with failures of at least one
graft in 5 and patency identified in 2.
Table 2. Cardiopulmonary exercise testing (CPET) variables of the 3 tests conducted on 39 patients.
1st CPET 2nd CPET 3rd CPET P
Baseline HR (bpm) 69.62 ± 2.32 67.23 ± 2.14 67.21 ± 2.49 0.04*
Anaerobic threshold
Workload (watts) 38.46 ± 4.17 33.57 ± 2.70 32.87 ± 2.57
HR (bpm) 90.77 ± 2.44 89.89 ± 2.47 90.36 ± 2.37
%HRmax 56.32 ± 1.52% 56.12 ± 1.62% 55.92 ± 1.46%
VO2 (mL/min) 732.6 ± 28.61 745.86 ± 25.16 871.77 ± 26.43 <0.0001*
RER 0.880 ± 0.010 0.870 ± 0.010 0.910 ± 0.020
VO2/HR 8.22 ± 0.33 8.43 ± 0.35 9.51 ± 0.32 <0.0001*
Peak stress
Workload (watts) 75.05 ± 4.23 75.79 ± 3.62 32.87 ± 2.56 0.0001*
HR (bpm) 119.2 ± 2.84 116.03 ± 2.85 90.36 ± 2.37 <0.0001*
%HRmax 74.45 ± 1.78% 72.35 ± 1.77% 55.92 ± 1.46% <0.0001*
VO2 (mL/min) 1148.15 ± 40.32 1187.1 ± 45.11 871.77 ± 26.33 <0.0001*
%Predicted VO2max 52.66 ± 1.84% 53.16 ± 2.1% 40.89 ± 1.46% <0.0001*
RER 1.13 ± 0.02 1.12 ± 0.02 0.91 ± 0.02 <0.0001*
VO2/HR 9.79 ± 0.37 10.28 ± 0.43 9.51 ± 0.32 0.03*
Data are reported as means ± SEM. HR = heart rate (bpm); %HRmax = percentage of maximal HR;
VO2 = oxygen uptake; RER = respiratory exchange ratio (VCO2/VO2); VO2/HR (mL/bpm) = oxygen
pulse; % predicted VO2max = percentage of predicted maximal exercise oxygen uptake. *P < 0.05, 3rd
CPET compared to 1st CPET and 2nd CPET (ANOVA).
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Table 3. Summed stress score (SSS), summed difference score (SDS) peak/prescription exercise, summed rest score for 39
patients.
Score (1) vs (2) Mean (median) ± SEM (1) Mean (median) ± SEM (2) P
SSS peak vs summed rest score 13.90 (12) ± 1.69 6.44 (4) ± 1.16 <0.0001t
SSS prescription exercise vs summed rest score 10.77 (9) ± 1.52 6.44 (4) ± 1.16 <0.0001t
SSS peak vs SSS prescription exercise 13.90 (12) ± 1.69 10.77 (9) ± 1.52 <0.0001t
SDS peak vs SDS prescription exercise 7.46 (5) ± 1.00 4.33 (2) ± 0.76 <0.0001w
SDS peak - SDS prescription exercise (≥2) 10.09 (9) ± 1.40 6.83 (6) ± 0.99 0.003w
Data are reported as means ± SEM and median. P < 0.05 (statistically significant difference between groups). t = t-test; w = Wilcoxon
test.
Baseline cardiopulmonary exercise test for the first
myocardial perfusion SPECT
Mean workload achieved was 75.05 ± 4.23 watts.
Mean HR ranged from 69.62 ± 2.32 bpm at rest to 119.2 ±
2.84 bpm at peak stress. 99mTc-sestamibi was injected at
approximately 114.61 ± 2.70 bpm, corresponding to 71.47
± 1.67% of age-predicted maximal HR and 52.66 ± 1.84%
of predicted VO2max. ST-segment depression ≥1 mm
occurred in 20 patients (51.20%), angina pectoris in 11
(28.20%), and intermittent claudication in 1 (2.56%).
Second cardiopulmonary exercise test for the determi-
nation of the level of exercise prescription
The anaerobic threshold was reached at a mean work-
load of 33.57 ± 2.70 watts and mean HR of 89.89 ± 2.47
bpm, corresponding to 56.12 ± 1.62% of age-predicted
maximal HR.
Third cardiopulmonary exercise test during prescribed
exercise based on the anaerobic threshold in order to
obtain the 2nd myocardial perfusion SPECT
Mean prescribed workload was 32.87 ± 2.56 watts.
Mean HR during exercise training was 90.36 ± 2.37 bpm,
corresponding to 55.92 ± 1.46% of age-predicted maximal
heart rate and 40.89 ± 1.46% of predicted VO2max. HR at
the time of 99mTc-sestamibi injection was 91.41 ± 2.38
bpm, corresponding to 57.01 ± 1.58% of age-predicted
maximal HR and 40.89 ± 1 46% of predicted VO2max. Only
7 patients (18%) had ST-segment depression ≥1 mm,
while 32 patients (82%) showed no ECG changes. Only 2
patients (5.12%) experienced angina pectoris.
Heart rate comparison
There was a significant difference between HR at peak
stress (114 ± 2.70 bpm) and prescribed exercise (91 ± 2.38
bpm; P = 0.001) regarding 99mTc-sestamibi injection, corre-
sponding to 71 ± 1.67 and 57 ± 1.52% of age-predicted
maximal HR, respectively. No differences were found be-
tween heart rate at the time of 99mTc-sestamibi injection
during prescribed exercise (91 ± 2.38 bpm) and the pre-
scribed HR (90 ± 2.37 bpm). Peak HR was significantly
higher during prescribed exercise than at rest (67 ± 2.49
bpm; P < 0.0001) and was significantly higher 119 ± 2.84
bpm than prescribed HR (P < 0.0001).
Myocardial perfusion SPECT
Significant differences (P < 0.0001) were found be-
tween mean scores of SPECT images at rest (6.44, 95%CI
= 4.09-8.79), peak stress (13.90, 95%CI = 10.48-17.32),
and prescribed exercise (10.77, 95%CI = 7.69-13.85) (Table
3). When myocardial ischemia was defined as a difference
≥2 between the summed stress score and summed rest
score, the summed difference score was 10.09 ± 1.40 at
peak exercise and 6.83 ± 0.99 during prescription exercise
(Table 3). Individual analysis showed that during prescrip-
tion exercise the summed difference score was ≥2 in 25
(64%) patients and <2 in 14 (36%). Among the clinical
characteristics considered, namely, prior history of myo-
cardial infarction, prior revascularization, ST-segment de-
pression, and angiographic features, only the latter was
significantly different between groups. The incidence of
three-vessel disease was greater in the group with a
summed difference score ≥2 (Table 4).
Discussion
Among the several methods used to prescribe exer-
cise intensity for coronary artery disease patients, cardio-
pulmonary exercise testing to determine the anaerobic
threshold has come to the forefront, not only because of its
widespread availability but also because it is an extremely
valuable tool for risk stratification of patients with conges-
tive heart failure at tertiary cardiac centers. In post-myo-
cardial infarction patients receiving beta-blockers, the an-
aerobic threshold has been considered to be a “gold stand-
ard” for exercise prescription (22). The use of the V-slope
method to determine training intensity is individualized,
since it depends on patient age and fitness level. It is
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submaximal and predominantly aerobic, allowing exer-
cises to be performed for prolonged periods (23). The
anaerobic threshold has the advantage of being independ-
ent of patient motivation and thus more objective and
reproducible than maximal oxygen uptake (23,24). How-
ever, it has not been established whether this type of
prescription is sufficiently safe according to current guide-
lines, which recommend that exercise should be prescribed
for patients with coronary artery disease at a level that
does not elicit myocardial ischemia, characterized by an-
gina pectoris and/or ST-segment depression (2).
The present study is justified because exercise inten-
sity immediately below the ischemic threshold has been
proven to produce myocardial ischemia, as measured by
SPECT scanning (7,25). This may be accomplished by
clinical and electrocardiographic monitoring of the rehabili-
tation session. Yet, in some conditions such as post-acute
myocardial infarction, ventricular hypertrophy, and previ-
ous ST-segment changes, among others, myocardial per-
fusion SPECT permits a more accurate identification of the
presence of myocardial ischemia during a cardiac rehabili-
tation program. This method was used in the present study
because of its diagnostic superiority.
Although they did not constitute a homogeneous group,
the patients included in the present study had coronary
artery disease previously documented by coronary an-
giography. Thirty-one (79.5%) had at least two-vessel
disease and 8 (20.5%) had single-vessel disease, but with
at least 70% stenosis, justifying the presence of reduced
uptake on stress images.
All 39 patients had stable angina or were asymptomatic
and were being medically treated by their cardiologists
based on clinical and angiographic criteria. These charac-
teristics make these patients similar to those referred for
supervised rehabilitation. It can be noted that the group of
39 patients studied was significantly smaller than the initial
sample of 153 selected among patients routinely treated at
the Department of Nuclear Cardiology of our institution.
This may be explained by the need to exclude all patients
in whom ST-segment interpretation would be impaired by
their baseline conditions. In a Tertiary Center of Nuclear
Cardiology, an elevated number of patients are referred for
myocardial perfusion SPECT exactly because they cannot
be properly assessed by standard exercise stress testing.
Another reason for exclusion was patient difficulty in at-
tending a rehabilitation program.
By performing qualitative and semiquantitative SPECT
analyses, we could minimize potential biases associated
with qualitative interpretation alone. The use of a summed
difference score equal to or greater than 2 followed the
recommendations of the studies that introduced this tech-
nique (21).
Recently, a summed difference score of 2 was consid-
ered to be indicative of myocardial ischemia in the COUR-
AGE trial (21), a large multicenter study highly influential
among cardiologists. Therefore, the summed difference
Table 4. Clinical, angiographic and electrocardiographic data according to summed difference score
in exercise prescription for 39 patients.
Group A (≥2) Group B (<2) P
Number 25 (64%) 14 (36%)
Age (years) 60.4 ± 7.37 58.64 ± 8.22 0.497t
Hypertension 24 (96%) 13 (92.9%) 0.676f
Dyslipidemia 25 (67.6%) 12 (32.4%) 0.120f
Diabetes mellitus 12 (48%) 6 (42.9%) 0.757p
Smoking 3 (12%) 1 (7.1%) 0.870f
Past smoking 11 (44%) 7 (5%) 0.870f
Angina pectoris 1 (4%) 1 (7.1%) 1.000
Myocardial infarction 12 (48%) 5 (35.7%) 0.458p
Myocardial infarction and coronary artery bypass graft 7 (28%) 2 (14.3%) 0.330f
 surgery and/or percutaneous coronary intervention
Coronary artery bypass graft surgery 3 (12%) 3 (21.4%) 0.647f
and/or percutaneous coronary intervention
Single-vessel disease 2 (8%) 5 (35.7%) 0.075f
Two-vessel disease 14 (56%) 8 (57.1%) 0.945f
Three-vessel disease 9 (36%) 1 (7.1%) 0.048f*
ST-segment depression = 1 mm 6 (24%) 0% 0.139f
ST-segment depression >1 mm - 1 (7%) 0.359f
Myocardial ischemia is defined as a difference ≥2 between the summed stress score and the
summed rest score. *P < 0.05. t = t-test; f = Fisher exact test; p = Pearson chi-square test.
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score ≥2 found here in 25 patients (64%) suggests the
presence of exercise-induced myocardial ischemia. Al-
though the accuracy of SPECT imaging was not specifical-
ly evaluated in the present study, this had already been
done in a previous study performed at our institution,
showing a high degree of agreement among interpreta-
tions (k = 0.810) (26). Based on the difference between
the summed stress score and summed rest score, myocar-
dial ischemia, as measured by SPECT perfusion studies,
has been quantified as follows: 0-1 = no ischemia; 2-6 =
mild-to-moderate ischemia, and >6 = severe ischemia
(COURAGE). According to these criteria, 14 patients
(35.89%) had no ischemia, 15 (38.47%) had mild-to-mod-
erate ischemia, and 10 (25.64%) had severe ischemia.
One-fourth of our patients, therefore, had severe ischemia,
suggesting that these patients should have their clinical
and electrocardiographic parameters monitored during the
first sessions of a rehabilitation program. No significant
differences were found regarding age or clinical, angio-
graphic, and electrocardiographic data of patients with a
summed difference score ≥2 and <2, except for the pres-
ence of three-vessel disease (P = 0.048; Table 4). Perhaps
these patients would be candidates for a more thorough
clinical evaluation. Patients with myocardial ischemia docu-
mented by myocardial SPECT were prescribed workloads
below their anaerobic threshold and referred to a special
program consisting of interval training during all aerobic
phases of rehabilitation. Alternatively, these patients were
prescribed muscular resistance exercise at about 40% of
maximal contraction, for complementation.
The objective of this study was not to recommend the
routine use of myocardial perfusion SPECT to evaluate the
accuracy of exercise prescription in rehabilitation pro-
grams, but rather to open the possibility of using nuclear
medicine to assess the degree of ischemia induced by
regular rehabilitation exercises in selected patients.
Limitations: this study was conducted at a single center
on a small number of patients, and the female gender was
underrepresented. The study sample was a convenience
sample, i.e., it was composed of patients with ischemic
heart disease due to diffuse, extensive atherosclerotic
disease recruited from a tertiary center, and should not be
considered to be representative of the larger universe of
patients with ischemic heart disease for whom supervised
exercise programs are indicated.
Clinical implications: our results suggest that, in super-
vised exercise training programs, exercise prescription
based on the anaerobic threshold is still recommended for
coronary artery disease with stress-induced myocardial
ischemia. Nevertheless, because myocardial ischemia may
be present, the presence of ST-segment depression and
angina pectoris should determine a reduction in exercise
intensity. These recommendations are valid, even after
publication of the study by Noel et al. (27), which did not
find significant changes in the course of only 11 patients in
the presence of ST-segment depression of 1 mm. In pa-
tients with diffuse and severe coronary artery disease,
myocardial perfusion SPECT may be a useful adjunct for a
more appropriate and accurate detection of ischemia, since
it enables exercise to be prescribed more safely below the
ischemic zone, regardless of the anaerobic threshold.
Based on our results, the following conclusions can be
drawn: in patients with ischemic heart disease due to severe,
diffuse atherosclerosis, myocardial ischemia was detected
by 99mTc-sestamibi myocardial perfusion SPECT during the
continuous aerobic phase prescribed based on the anaero-
bic threshold, even in clinically stable patients. Angina pec-
toris and/or ischemic ECG changes have low sensitivity to
identify myocardial ischemia during the aerobic phase of a
cardiac rehabilitation session. The 64% prevalence of ische-
mia observed in the study should not be considered repre-
sentative of the entire population of patients undergoing an
exercise program. The changes in patient care and exercise
program were implemented as a result of our findings (ische-
mia during the prescribed exercise).
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